CagriSema
10 mg (lyophilized)
CAS #:
1415456-99-3 / 910463-68-2
Purity:
TBD
Cap colour is for illustration purposes only
CagriSema
10 mg (lyophilized)
+ $25 flat-rate shipping · free at $300+ · Interac e-Transfer ·
About this compound
CagriSema is a research blend of cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist, at 5 mg each. The pairing is used in preclinical research on appetite regulation, body-weight control and glucose metabolism by combining amylin and GLP-1 receptor signalling. It is supplied as a lyophilized powder for laboratory research only.
Key chemical details
- Common synonyms
- Cagrilintide + semaglutide blend
Storage and handling
Store at -20°C lyophilized, away from moisture and UV light. Keep vials sealed until use. Stable for 2+ years in a non-frost-free freezer.
Preclinical research references
Provided for informational context only. All cited studies involve preclinical or in vitro models. Results do not predict human safety or efficacy. These references do not constitute medical claims.
- Rodent obesity models examined combined amylin and GLP-1 receptor agonism on food intake and body weight
- Receptor studies characterised the distinct amylin and GLP-1 pathways engaged by each component
- Preclinical glycaemic studies examined insulin sensitivity and glucose-handling endpoints
Shipping & returns
1–5 business days (5–7 for BC, NL and remote areas), Canada-wide tracked courier, double tamper-proof packaging.
All sales final. Damaged or incorrect orders must be reported within 24 hours with photos.
Every batch independently tested for purity. COA on file and available before purchase.
FAQ — CagriSema
For research use only. Not for human or veterinary administration.